These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

911 related items for PubMed ID: 22447120

  • 1. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
    Hucke S, Floßdorf J, Grützke B, Dunay IR, Frenzel K, Jungverdorben J, Linnartz B, Mack M, Peitz M, Brüstle O, Kurts C, Klockgether T, Neumann H, Prinz M, Wiendl H, Knolle P, Klotz L.
    Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.
    Feinstein DL, Galea E, Gavrilyuk V, Brosnan CF, Whitacre CC, Dumitrescu-Ozimek L, Landreth GE, Pershadsingh HA, Weinberg G, Heneka MT.
    Ann Neurol; 2002 Jun; 51(6):694-702. PubMed ID: 12112074
    [Abstract] [Full Text] [Related]

  • 3. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation.
    Hesske L, Vincenzetti C, Heikenwalder M, Prinz M, Reith W, Fontana A, Suter T.
    Brain; 2010 Jun; 133(Pt 6):1637-54. PubMed ID: 20424288
    [Abstract] [Full Text] [Related]

  • 4. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity.
    Ponomarev ED, Shriver LP, Maresz K, Dittel BN.
    J Neurosci Res; 2005 Aug 01; 81(3):374-89. PubMed ID: 15959904
    [Abstract] [Full Text] [Related]

  • 5. CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system.
    Mildner A, Mack M, Schmidt H, Brück W, Djukic M, Zabel MD, Hille A, Priller J, Prinz M.
    Brain; 2009 Sep 01; 132(Pt 9):2487-500. PubMed ID: 19531531
    [Abstract] [Full Text] [Related]

  • 6. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS, Huston K, Shaw M, Tse HY, Raine CS.
    Lab Invest; 1994 Nov 01; 71(5):671-9. PubMed ID: 7526038
    [Abstract] [Full Text] [Related]

  • 7. Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB.
    Taoufik E, Tseveleki V, Chu SY, Tselios T, Karin M, Lassmann H, Szymkowski DE, Probert L.
    Brain; 2011 Sep 01; 134(Pt 9):2722-35. PubMed ID: 21908876
    [Abstract] [Full Text] [Related]

  • 8. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC, Lalor SJ, Lynch MA, Mills KH.
    Brain Behav Immun; 2010 May 01; 24(4):641-51. PubMed ID: 20138983
    [Abstract] [Full Text] [Related]

  • 9. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.
    Haroon F, Drögemüller K, Händel U, Brunn A, Reinhold D, Nishanth G, Mueller W, Trautwein C, Ernst M, Deckert M, Schlüter D.
    J Immunol; 2011 Jun 01; 186(11):6521-31. PubMed ID: 21515788
    [Abstract] [Full Text] [Related]

  • 10. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
    Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H.
    PLoS Med; 2007 Apr 01; 4(4):e124. PubMed ID: 17425404
    [Abstract] [Full Text] [Related]

  • 11. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.
    Blyszczuk P, Kania G, Dieterle T, Marty RR, Valaperti A, Berthonneche C, Pedrazzini T, Berger CT, Dirnhofer S, Matter CM, Penninger JM, Lüscher TF, Eriksson U.
    Circ Res; 2009 Oct 23; 105(9):912-20. PubMed ID: 19762681
    [Abstract] [Full Text] [Related]

  • 12. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis.
    Linker RA, Lee DH, Demir S, Wiese S, Kruse N, Siglienti I, Gerhardt E, Neumann H, Sendtner M, Lühder F, Gold R.
    Brain; 2010 Aug 23; 133(Pt 8):2248-63. PubMed ID: 20826430
    [Abstract] [Full Text] [Related]

  • 13. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.
    Prinz M, Schmidt H, Mildner A, Knobeloch KP, Hanisch UK, Raasch J, Merkler D, Detje C, Gutcher I, Mages J, Lang R, Martin R, Gold R, Becher B, Brück W, Kalinke U.
    Immunity; 2008 May 23; 28(5):675-86. PubMed ID: 18424188
    [Abstract] [Full Text] [Related]

  • 14. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
    Klotz L, Hucke S, Thimm D, Classen S, Gaarz A, Schultze J, Edenhofer F, Kurts C, Klockgether T, Limmer A, Knolle P, Burgdorf S.
    J Immunol; 2009 Jul 01; 183(1):129-36. PubMed ID: 19535643
    [Abstract] [Full Text] [Related]

  • 15. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice.
    Tran EH, Hoekstra K, van Rooijen N, Dijkstra CD, Owens T.
    J Immunol; 1998 Oct 01; 161(7):3767-75. PubMed ID: 9759903
    [Abstract] [Full Text] [Related]

  • 16. Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions.
    Ifergan I, Kebir H, Terouz S, Alvarez JI, Lécuyer MA, Gendron S, Bourbonnière L, Dunay IR, Bouthillier A, Moumdjian R, Fontana A, Haqqani A, Klopstein A, Prinz M, López-Vales R, Birchler T, Prat A.
    Ann Neurol; 2011 Nov 01; 70(5):751-63. PubMed ID: 22162058
    [Abstract] [Full Text] [Related]

  • 17. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system.
    Na SY, Cao Y, Toben C, Nitschke L, Stadelmann C, Gold R, Schimpl A, Hünig T.
    Brain; 2008 Sep 01; 131(Pt 9):2353-65. PubMed ID: 18669487
    [Abstract] [Full Text] [Related]

  • 18. Expression of the HGF receptor c-met by macrophages in experimental autoimmune encephalomyelitis.
    Moransard M, Sawitzky M, Fontana A, Suter T.
    Glia; 2010 Apr 01; 58(5):559-71. PubMed ID: 19941340
    [Abstract] [Full Text] [Related]

  • 19. Selective inhibition of CCR2 expressing lymphomyeloid cells in experimental autoimmune encephalomyelitis by a GM-CSF-MCP1 fusokine.
    Rafei M, Campeau PM, Wu JH, Birman E, Forner K, Boivin MN, Galipeau J.
    J Immunol; 2009 Mar 01; 182(5):2620-7. PubMed ID: 19234156
    [Abstract] [Full Text] [Related]

  • 20. Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis.
    Elhofy A, Wang J, Tani M, Fife BT, Kennedy KJ, Bennett J, Huang D, Ransohoff RM, Karpus WJ.
    J Leukoc Biol; 2005 Feb 01; 77(2):229-37. PubMed ID: 15539456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.